Neogen Corporation (NASDAQ:NEOG) Given Consensus Recommendation of “Hold” by Analysts

Shares of Neogen Corporation (NASDAQ:NEOG) have received an average recommendation of “Hold” from the six brokerages that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating on the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $8.8333.

Several analysts have weighed in on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Neogen in a research note on Monday. Wall Street Zen upgraded shares of Neogen from a “hold” rating to a “buy” rating in a research note on Saturday, December 13th. CJS Securities upgraded Neogen from a “market perform” rating to an “outperform” rating and set a $10.00 price target on the stock in a research report on Wednesday, December 10th. Finally, Piper Sandler set a $6.50 price target on Neogen and gave the company a “neutral” rating in a report on Thursday, October 16th.

Neogen Stock Performance

Shares of NASDAQ:NEOG opened at $7.20 on Friday. The company has a debt-to-equity ratio of 0.37, a current ratio of 3.58 and a quick ratio of 2.26. The business’s fifty day moving average price is $6.22 and its two-hundred day moving average price is $5.66. Neogen has a fifty-two week low of $3.87 and a fifty-two week high of $13.40. The stock has a market capitalization of $1.56 billion, a price-to-earnings ratio of -1.50 and a beta of 1.99.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in NEOG. Vanguard Group Inc. increased its position in Neogen by 1.6% in the 3rd quarter. Vanguard Group Inc. now owns 23,963,223 shares of the company’s stock valued at $136,830,000 after acquiring an additional 385,885 shares in the last quarter. ING Groep NV acquired a new stake in shares of Neogen in the third quarter valued at approximately $80,288,000. Clarkston Capital Partners LLC raised its position in Neogen by 123.2% in the 2nd quarter. Clarkston Capital Partners LLC now owns 14,005,725 shares of the company’s stock worth $66,947,000 after purchasing an additional 7,729,650 shares during the last quarter. Gates Capital Management Inc. acquired a new position in Neogen during the 1st quarter worth $79,391,000. Finally, Norges Bank bought a new position in Neogen in the 2nd quarter valued at $43,387,000. 96.73% of the stock is owned by institutional investors.

Key Neogen News

Here are the key news stories impacting Neogen this week:

• Positive Sentiment: Zacks raised its Q1 2028 EPS estimate to $0.09 from $0.07, signaling one analyst sees improvement in early?2028 profitability — MarketBeat NEOG
• Neutral Sentiment: Neogen announced its second?quarter earnings release date, a near?term catalyst that can increase volatility around the report and guide investors on updated results and outlook. Earnings Release Date
• Negative Sentiment: Zacks Research cut multiple near?term and FY estimates across several quarters (examples: Q2 2026 to $0.06 from $0.07; Q2 2027 to $0.08 from $0.09; FY2026 to $0.25 from $0.28; FY2027 to $0.30 from $0.35). These downward revisions reduce near?term earnings expectations and likely pressured the stock. The firm still notes a consensus full?year EPS of $0.38, but the trend of cuts is the main negative driver. Zacks / MarketBeat
• Negative Sentiment: Yahoo Finance published a bullish?to?bearish pieces titled “3 Reasons to Sell NEOG and 1 Stock to Buy Instead,” which can amplify selling pressure by highlighting fundamental or valuation concerns to retail investors. Sell Article

About Neogen

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user?friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.